57365-08-9,
2-Amino-N-cyclohexyl-N-methylbenzylamine,
2-((Cyclohexyl(methyl)amino)methyl)aniline,
2-[[cyclohexyl(methyl)amino]methyl]aniline,
2-{[cyclohexyl(methyl)amino]methyl}aniline,
N-(2-Aminobenzyl)-N-methylcyclohexanamine,
2-Amino-N-cyclohexyl-N-methylbenzenemethanamine,
Benzenemethanamine, 2-amino-N-cyclohexyl-N-methyl-,
[(2-aminophenyl)methyl]cyclohexylmethylamine,
EINECS 260-701-4,
Bromhexine Impurity C,
AC1Q4TVS,
ACMC-20ao43,
AC1L3QM8,
3-methoxy-4-fluorobenzoicacid,
SCHEMBL365219,
CTK8C6068,
ZINC57065,
DTXSID30205965,
MFCD00674077,
SBB057187,
AKOS000120825,
MCULE-8399053283,
TRA0007453,
TC-170922,
2-[(Cyclohexylmethylamino)methyl]phenylamine,
FT-0661697,
ST50319704,
X4594,
2-Amino-N-cyclohexyl-N-methylbenzylamine, 98%,
N|A-cyclohexyl-N|A-methyltoluene-|A,2-diamine,
Bromhexine impurity C, European Pharmacopoeia (EP) Reference Standard,
Bromhexine EP Impurity C,
4-Fluoro-3-methoxybenzoic acid,
C14H22N2,
CID93648,
AR-1D7519,
C14-H22-N2,
CS-O-07414,
A10061,
2-AMINO-N-CYCLOHEXYL-N-METHYLBENZENEMETHAMINEHCL,
59094-49-4,
82846-18-2,